Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Nanodrug delivery in reversing multidrug resistance in cancer cells.

Kapse-Mistry S, Govender T, Srivastava R, Yergeri M.

Front Pharmacol. 2014 Jul 10;5:159. doi: 10.3389/fphar.2014.00159. eCollection 2014. Review.

2.

Mesoporous iron oxide nanoparticles prepared by polyacrylic acid etching and their application in gene delivery to mesenchymal stem cells.

Cao B, Qiu P, Mao C.

Microsc Res Tech. 2013 Sep;76(9):936-41. doi: 10.1002/jemt.22251. Epub 2013 Jul 30.

3.

Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53.

Morad SA, Madigan JP, Levin JC, Abdelmageed N, Karimi R, Rosenberg DW, Kester M, Shanmugavelandy SS, Cabot MC.

Biochem Pharmacol. 2013 Apr 15;85(8):1057-65. doi: 10.1016/j.bcp.2013.01.015. Epub 2013 Jan 24.

4.

Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Merrill AH Jr.

Chem Rev. 2011 Oct 12;111(10):6387-422. doi: 10.1021/cr2002917. Epub 2011 Sep 26. Review. No abstract available.

5.

P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.

Chapman JV, Gouazé-Andersson V, Karimi R, Messner MC, Cabot MC.

Exp Cell Res. 2011 Jul 15;317(12):1736-45. doi: 10.1016/j.yexcr.2011.03.004. Epub 2011 Mar 21.

6.

Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications.

Yavlovich A, Smith B, Gupta K, Blumenthal R, Puri A.

Mol Membr Biol. 2010 Oct;27(7):364-81. doi: 10.3109/09687688.2010.507788. Epub 2010 Oct 13. Review.

7.

Growth factor delivery-based tissue engineering: general approaches and a review of recent developments.

Lee K, Silva EA, Mooney DJ.

J R Soc Interface. 2011 Feb 6;8(55):153-70. doi: 10.1098/rsif.2010.0223. Epub 2010 Aug 18. Review.

8.

Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R.

Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-80. Review.

9.

A novel size-tunable nanocarrier system for targeted anticancer drug delivery.

Li Y, Xiao K, Luo J, Lee J, Pan S, Lam KS.

J Control Release. 2010 Jun 15;144(3):314-23. doi: 10.1016/j.jconrel.2010.02.027. Epub 2010 Mar 6.

10.

Ceramide signaling in cancer and stem cells.

Bieberich E.

Future Lipidol. 2008 Jun;3(3):273-300.

Items per page

Supplemental Content

Write to the Help Desk